講者：查岱龍
日期：2016-05-10
觀看: 1442
  • 00:00 1.
    Role of energery ablation therapy - HIFU
  • 00:24 2.
    TSGH experience - HIFU
  • 00:25 3.
    HIFU preparation (TSGH)
  • 01:08 4.
    TSGH Experience on HIFU
  • 01:24 5.
    TSGH Experience on HIFU
  • 01:54 6.
    TSGH Experience on HIFU
  • 02:22 7.
    TSGH Experience on HIFU
  • 03:01 8.
    Complication
  • 03:25 9.
    HIFU failure criteria
  • 03:56 10.
    Slide 10
  • 05:34 11.
    Slide 10
  • 06:19 12.
    Salvage therapy for disease recurrence after HIFU treatment in our series
  • 06:20 13.
    Slide 10
  • 06:20 14.
    Salvage therapy for disease recurrence after HIFU treatment in our series
  • 08:00 15.
    Case series of HIFU for localized prostate cancer considering the complications
  • 10:18 16.
    Review of literatures
  • 索引
  • 筆記
  • 全螢幕
【醫藥護人員場】10. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-HIFU治療
長度: 10:24, 瀏覽: 1443, 最近修訂: 2017-05-09
演講時間：10:30-11:30
講者：查岱龍主任 
現任職位/稱：
三軍總醫院外科部主任
國防醫學院外科學系教授
台灣泌尿科醫學會理事
美國德州大學安德森癌症中心博士
 
 
    上一篇 下一篇
    • 00:00 1.
      Role of energery ablation therapy - HIFU
    • 00:24 2.
      TSGH experience - HIFU
    • 00:25 3.
      HIFU preparation (TSGH)
    • 01:08 4.
      TSGH Experience on HIFU
    • 01:24 5.
      TSGH Experience on HIFU
    • 01:54 6.
      TSGH Experience on HIFU
    • 02:22 7.
      TSGH Experience on HIFU
    • 03:01 8.
      Complication
    • 03:25 9.
      HIFU failure criteria
    • 03:56 10.
      Slide 10
    • 05:34 11.
      Slide 10
    • 06:19 12.
      Salvage therapy for disease recurrence after HIFU treatment in our series
    • 06:20 13.
      Slide 10
    • 06:20 14.
      Salvage therapy for disease recurrence after HIFU treatment in our series
    • 08:00 15.
      Case series of HIFU for localized prostate cancer considering the complications
    • 10:18 16.
      Review of literatures
    位置
    1. 知識庫
    2. ...
    3. 2016臺大攝護祭-醫藥護人員場
    資料夾名稱
    2016臺大攝護祭-醫藥護人員場
    發表人
    系統管理者
    單位
    泌尿部
    建立
    2016-05-10 12:34:00
    最近修訂
    2017-05-09 09:59:00
    長度
    10:24
    1. 知識庫
    2. ...
    3. 2016臺大攝護祭-醫藥護人員場
    1. 1.
      【醫藥護人員場】活動議程
    2. 2.
      【醫藥護人員場】1. Updates of Prostate Cancer Treatment Guidelines 2015/2016: EAU, NCCN, AUA
    3. 3.
      【醫藥護人員場】2. Prostate Cancer Screening、Observation、and Active Surveillance in Taiwan
    4. 4.
      【醫藥護人員場】3. Novel Therapies for Patients with Metastatic Prostate Cancer
    5. 5.
      【醫藥護人員場】4. Radium-223 (Xofigo, 鐳治骨)
    6. 6.
      【醫藥護人員場】5. Enzalutamide (Xtandi, 安可坦)
    7. 7.
      【醫藥護人員場】6. Denosumab (XGEVA, 癌骨瓦)
    8. 8.
      【醫藥護人員場】7. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-根除手術
    9. 9.
      【醫藥護人員場】8. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-放射治療
    10. 10.
      【醫藥護人員場】9. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-冷凍治療
    11. 11.
      【醫藥護人員場】10. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-HIFU治療
    12. 12.
      【醫藥護人員場】11. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-綜合比較與總結
    13. 13.
      【醫藥護人員場】12. Novel Life-Prolonging Endocrine Therapies for Metastatic Castration-Resistant Prostate Cancer
    14. 14.
      【醫藥護人員場】13. Medical and Surgical Treatment of Male Urinary Incontinence
    15. 15.
      【醫藥護人員場】14. Prevention and Management of Acute Urinary Retention in Men with Prostate Hypertrophy
    16. 16.
      【醫藥護人員場】15. The Art of Treatment for Nocturia
    17. 17.
      【醫藥護人員場】16. Storage Urinary Symptoms: 2016 Updates
    18. 18.
      【醫藥護人員場】17. Surgical Treatments for Prostate Hypertrophy with Urinary Symptoms 2016
    Copyright © 2017 TMUA, All rights reserved.